Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound

Doxorubicin (DOX) is a representative anticancer drug with a unique ability to induce immunogenic cell death of cancer cells. However, undesired toxicity on immune cells has remained a significant challenge, hindering the usage of DOX in cancer immunotherapy. Here, we report a combined therapy to av...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeongjin, Um, Wooram, Moon, Hyungwon, Joo, Hyeyeon, Song, Yeari, Park, Minsung, Yoon, Been, Kim, Hyun-Ryoung, Park, Jae Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784431/
https://www.ncbi.nlm.nih.gov/pubmed/36559097
http://dx.doi.org/10.3390/pharmaceutics14122603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784431/
https://www.ncbi.nlm.nih.gov/pubmed/36559097
http://dx.doi.org/10.3390/pharmaceutics14122603

Ejemplares similares